FDA approves device for treatment of acute coronary artery perforations
The U.S. Food and Drug Administration today approved a device intended to treat acute coronary artery perforations, or tears in the blood vessels of the heart. The PK Papyrus Covered Coronary Stent System is the first device approved by the FDA for this indication in 17 years.
“An acute coronary artery perforation is a rare, but potentially life-threatening complication of heart vessel procedures,” said Bram Zuckerman, M.D., director of the Division of Cardiovascular Devices in the FDA’s Center for Devices and Radiological Health. “The PK Papyrus Covered Coronary Stent System provides health care providers with a new treatment option that can seal the perforation in order to stop blood leakage during the procedure and avoid a potentially life-threatening complication or a more invasive surgical procedure.”
9/10/18: In an effort to alert the public – particularly those who speak Spanish – about the prevalence and seriousness of kidney disease among Hispanics and the urgent need for more living kidney donors, the National Kidney Foundation (NKF) has produced two, new 30-second, Spanish-language video public service announcements for media across the country.
9/7/18: "These are exciting preliminary findings because hepatocellular carcinoma is the most common form of liver cancer, and microbubbles appear to sensitize the tumor to the radiation therapy," Dr. Eisenbrey said.
9/7/18: The HLAA Walk4Hearing has raised more than $13 million and welcomed more than 90,000 walkers in cities across the country since its inception in 2006. Funds raised support national and local programs for people with hearing loss.